Thierry Hauet

Title: Innovations of Thierry Hauet

Introduction

Thierry Hauet is a notable inventor based in Mignaloux Beauvoir, France. He has made significant contributions to the field of pharmaceuticals, particularly in the area of cellular health and neuroprotection. With a total of three patents to his name, Hauet's work focuses on innovative compounds that target programmed cell death.

Latest Patents

Hauet's latest patents include groundbreaking research on natural product derivatives for inhibiting cellular necroptosis, ferroptosis, and oxytosis. The inventions relate to compounds designed to serve as drugs, specifically aimed at inhibiting programmed cell death pathways. These compounds are also intended for neuroprotection and for preventing or treating disorders associated with cellular necroptosis or ferroptosis. Additionally, his patents encompass pharmaceutical compositions that include these compounds, as well as their use in organ preservation.

Career Highlights

Throughout his career, Thierry Hauet has worked with esteemed institutions such as Université de Poitiers and Centre Hospitalier Universitaire de Poitiers. His research has contributed to advancements in medical science, particularly in understanding and combating cellular death mechanisms.

Collaborations

Hauet has collaborated with notable colleagues, including Stéphane Bach and Marie-Thérèse Dimanche-Boitrel. These partnerships have further enriched his research and innovation efforts.

Conclusion

Thierry Hauet's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to advancing medical science. His work in inhibiting cellular death pathways is paving the way for new therapeutic approaches.